# The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients

> **NCT00338338** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 70 (—)

## Conditions studied

- Uncomplicated Hypertension
- Hypertension
- Essential

## Interventions

- **DRUG:** Lacidipine 4 or 6 mg (oral)
- **DRUG:** Amlodipine 5 or 10 mg(oral)

## Key facts

- **NCT ID:** NCT00338338
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-07
- **Primary completion:** 2007-09-14
- **Final completion:** 2007-09-14
- **Target enrollment:** 70 (—)
- **Last updated:** 2017-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00338338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00338338, "The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00338338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*